• Study
    • Undergraduate
    • Postgraduate
    • International
    • Professional Education
    • Institute of Medical and Biomedical Education
    • Faculty of Health, Social Care and Education
    • Student life
    • Graduation stories
    • Accommodation
    • Open Days
    • Medical Electives
    • Download a prospectus
    • Contact us
    • Course terms
    • Term Dates
    • Application
    • Summer School
    • Postgraduate 2018
    • Courses for NHS staff
  • Home
  • Research
    • Molecular and Clinical Sciences
    • Infection and immunity
    • Population health
    • Research news
    • Researchers A-Z
    • Facilities
    • Research degrees and training
    • Partners
    • Working with us
    • Research Excellence
    • Openness in animal research
    • Wellcome Trust Institutional Strategic Support Fund
    • St George’s Academic Training (GAT)
  • Business
    • Collaborate
    • Consultancy
    • The Image Resource Facility
    • Filming
    • Retail tenancies
    • Accommodation
    • Intellectual property
    • Conference facilities
  • Alumni
    • Keep in touch
    • Support
    • Volunteering
    • Alumni news
    • What we offer
    • Data Protection Statement
    • Donate
    • Graduate Outcomes
    • Obituaries
  • About
    • What we do
    • St George’s: A Timeline
    • Principal
    • Governance
    • Financial facts
    • Our partners
    • Join us
    • How to get here
    • Widening participation
    • EU referendum
    • Strategy 2017-2022
    • NHS 70th Birthday
  • News
    • News and features
    • Public events
    • Annual review
    • Contact us
St George's University Home
  • Twitter
  • Facebook
  • YouTube
  • Google Plus
  • Instagram
Menu
  • Study
    • Undergraduate
    • Postgraduate
    • International
    • Professional Education
    • Institute of Medical and Biomedical Education
    • Faculty of Health, Social Care and Education
    • Student life
    • Graduation stories
    • Accommodation
    • Open Days
    • Medical Electives
    • Download a prospectus
    • Contact us
    • Course terms
    • Term Dates
    • Application
    • Summer School
    • Postgraduate 2018
    • Courses for NHS staff
  • Home
  • Research
    • Molecular and Clinical Sciences
    • Infection and immunity
    • Population health
    • Research news
    • Researchers A-Z
    • Facilities
    • Research degrees and training
    • Partners
    • Working with us
    • Research Excellence
    • Openness in animal research
    • Wellcome Trust Institutional Strategic Support Fund
    • St George’s Academic Training (GAT)
  • Business
    • Collaborate
    • Consultancy
    • The Image Resource Facility
    • Filming
    • Retail tenancies
    • Accommodation
    • Intellectual property
    • Conference facilities
  • Alumni
    • Keep in touch
    • Support
    • Volunteering
    • Alumni news
    • What we offer
    • Data Protection Statement
    • Donate
    • Graduate Outcomes
    • Obituaries
  • About
    • What we do
    • St George’s: A Timeline
    • Principal
    • Governance
    • Financial facts
    • Our partners
    • Join us
    • How to get here
    • Widening participation
    • EU referendum
    • Strategy 2017-2022
    • NHS 70th Birthday
  • News
    • News and features
    • Public events
    • Annual review
    • Contact us
Search
You are here: Home Research profiles A-Z Dr Angela Loyse

Dr Angela Loyse

  • Molecular and Clinical Sciences
  • Infection and immunity
  • Population health
  • Research news
  • Research profiles A-Z
  • Facilities
  • Partners
  • Working with us

Research

Angela Loyse is an infectious diseases clinician and researcher (clinical and implementation) in the fields of advanced AIDS disease and, in particular, HIV-related meningo-encephalitis.

She is the chief investigator of the EDCTP/ANRS funded DREAMM project that aims to effectively and sustainably drive down HIV-related meningo-encephalitis mortality in three sites in Africa in collaboration with Dr Sayoki Mfinanga (National Institute Medical Research, Tanzania), Dr Cecilia Kanyama (UNC Project Malawi, Lilongwe) and Dr Charles Kouanfack (Hȏpital Central Yaoundé, Cameroon). The project is backed by Institut Pasteur.

The DREAMM project has led to the conception of two sister scientific projects:

  1. the development and evaluation of polyvalent diagnostic tests in collaboration with Institut Pasteur and industry
  2. the optimisation of nanopore technology for the diagnosis of HIV-associated meningo-encephalitis in resource limited settings.

Another key role is as chair of the cryptoMAG advocacy group which aims to improve access to diagnostic tests and essential antifungal medicines for HIV-associated cryptococcal meningitis in low-income and middle-income countries (LMICs).

Stakeholders include Centers for Disease Prevention and Control, Médecins sans Frontières (MSF), Clinton Health Action Initiative (CHAI) and others.

Angela is a lead investigator on the REFINE trial and has helped shape the project to potentially inform WHO guidelines on the management of advanced HIV disease. She has also played a key role in the recently completed ACTA trial, helping clinch additional French funding from ANRS for two sites in Cameroon, and assists Dr Mfinanga in the conduct of the TRIP trial of implementation of cryptococcal antigen screening in Tanzania.

Biography

She first became interested in infectious diseases research whilst at King’s College London medical school. Her specialist postgraduate clinical training in infectious diseases is ongoing at St George’s University Hospitals NHS Foundation Trust (start date 2009). 

Key qualifications and posts

July 2016

Senior Academic Lecturer

Honorary Infectious Diseases Consultant

August 2016

Chief investigator DREAMM (Driving Reduced AIDS-associated meningo-encephalitis Mortality) project.

Investigator TRIP (Translating Research into Practice)

Co-investigator AMBITION trial. Multi-centre trial of liposomal Amphotericin B for the treatment of HIV-associated meningo-encephalitis in Africa.

Diagnostic test development and evaluation. Work with diagnostic test manufacturers. Conceptualised idea for polyvalent tests (HIV/cryptococcal antigen(CrAg)). Prototype now ready for evaluation. Lead for evaluation of this prototype and a new, semi-quantitative CrAg lateral flow assay in collaboration with Institut Pasteur.

October 2012 to July 2016

Duties: Clinical Academic Fellow.

ACTA Lead investigator (ACTA-Phase III multi-centre clinical trial on treatment regimens for cryptococcal meningitis in HIV patients)

ACTA Trial Management Group member

Associate chief investigator RIFASHORT trial

June 2013 to present

CryptoMAG advocacy group chair (nominated)

Invited talks

  • The DREAMM project-an update International AIDS Society (IAS) EDCTP/ANRS symposia, Paris, July 2017.
  • Cryptococcal meningitis in LMICs: access to effective treatments and diagnostic tests. 10th International Conference on Cryptococcosis (ICCC), Brazil, March 2017.
  • Driving REduced AIDS-associated meningo-encephalitis mortality in LMICs: the DREAMM project. ANRS Reunion du groupe de travail TB/VIH AC12 Paris, May 2017.
  • Cryptococcal meningitis in LMICs: access to effective treatments and diagnostic tests. International Society for Neglected Tropical Diseases (ISNTD) d3, May, London 2017.

Publications

Recent publications

  1. Síle F. Molloy, Tom Chiller, Gregory S. Greene…Thomas S. Harrison, Shabbar Jaffar, Angela Loyse. Cryptococcal meningitis: A neglected NTD? PLoS Negl Trop Dis 2017; 11(6): e0005575. https://doi.org/10.1371/journal.pntd.000557.
  2. Radha Rajasingham, Rachel M Smith, Benjamin J Park….Angela Loyse, David R Boulware. Global burden of HIV-associated cryptoccal meningitis: an updated analysis. Lancet Infectious Diseases 2017; Published online May 5, 2017 http://dx.doi.org/10.1016/S1473-3099(17)30243-8.
  3. P.Williamson, JN Jarvis, AA Panackal, MC Fisher, SF Molloy, A Loyse, TS Harrison. Cryptococcal meningitis: Epidemiology, immunology, diagnosis and therapy. Nature Review Neurology 2016 doi:10.1038/nrneurol.2016.167.
  4. T. Bicanic, C. Bottomley, A.Loyse et al. Toxicity of Amphotericin B deoxycholate-based induction therapy in patients with HIV-associated meningitis. Antimicrobial Agents and Chemotherapy 2015; 59 (12): 7224-7231.
  5. M.A Beale, W. Sabiti, EJ Robertson, KM Fuentes-Cabrejo, SJ O’Hanlon, JN Jarvis, A Loyse, G Meintjes, TS Harrison, RC May, MC Fisher, T Bicanic. Genotypic diversity is associated with clinical outcome and phenotype in cryptococcal meningitis across Southern Africa. Plos NTD 2015; 9(6): e00038.
  6. J.N. Jarvis, T. Bicanic, A. Loyse et al. Vitamin D deficiency in HIV-infected South Africans: Common, and not associated with susceptibility, immune response, or outcome in HIV-associated cryptococcal meningitis. Clinical Infectious Diseases 2014; DOI: 10.1093/cid/ciu349.

Key publications

  1. A Loyse, A Moodley, P Rich et al. Neurological, visual, and MRI brain scan findings in 87 South African patients with HIV-associated cryptococcal meningoencephalitis. Journal of Infection 2014. doi: 10.1016/j.jinf.2014.10.007.
  2. A Loyse, H Thangaraj, P Easterbrook et al. Cryptococcal meningitis: improving access to essential antifungal medicines in resource-poor countries. The Lancet Infectious Diseases 2013;13 (7):629-637.
  3. A Loyse, D. Wilson, G. Meintjes, JN Jarvis, T Bicanic, L Bishop, K Rebe, A Williams, S Jaffar, LG Bekker, R Wood, TS Harrison. Comparison of the early fungicidal activity of high dose fluconazole, voriconazole, and flucytosine, as second drugs given in combination with amphotericin B, for the treatment of HIV-associated cryptococcal meningitis. Clinical Infectious Diseases 2011; 54(1):121-8.

View Dr Loyse's ResearchGate page

Research group

Thomas S. Harrison

Tihana Bicanic

Sile Molloy

Claire Robb

Jack Adams

Muirgen Stack

Sarah Burton

Collaborations

Prof Olivier Lortholary-Institut Pasteur

Prof Francoise Dromer-Institut Pasteur

Ms Aude Sturny-Leclerc Institut Pasteur

Dr Sayoki Mfinanga-NIMR Tanzania

Dr Sokoine Lesikari- NIMR Tanzania

Dr Cecilia Kanyama- UNC Project Malawi

Dr Charles Kouanfack- Hȏpital Central Yaoundé

Prof Shabbar Jaffar-Liverpool School of Tropical Medicine

Prof Robin Bailey- London School of Tropical Medicine & Hygiene

Dr Nelesh Govender-National Institute Communicable Diseases, South Africa

Dr Tariq Sadiq, SGUL

Dr Sebastian Fuller, SGUL

Prof Anne-Marie Reid, SGUL

Funding

European & Developing Countries Clinical Trials Partnership (EDCTP) grant- AMBITION trial - August 2016

Co-investigator. Multi-centre trial of liposomal amphotericin B for the treatment of HIV-associated meningo-encephalitis. 15% salary obtained over 4 years

EDCTP DREAMM project - October 2015

EDCTP Diagnostic tools for poverty related diseases-Research and Innovation Action Call. 75% salary obtained for 4 years.

ANRS ACTA Funding-Written proposal & oral presentation in French. Secured funding for ACTA Cameroonian sites.

Chronological order and where possible including dates (month and year), title and funder details. Don’t include amounts of money.

Teaching

Dr Loyse was invited to talk on cryptococcosis on the Leeds BSMM course April 2017.

Angela Loyse

Name: Dr Angela Loyse

Position: Senior Clinical Lecturer

Clinical role: Honorary Infectious Diseases Consultant

Research institute: Institute of Infection and Immunity

Tel: 0208 725 0443

Email: This email address is being protected from spambots. You need JavaScript enabled to view it.


Contact

General enquiries

  • St George's, University of London
  • Cranmer Terrace
  • London SW17 0RE
  • (0)20 8672 9944

Connect with St George's

  • Twitter
  • Facebook
  • YouTube
  • Instagram

Quick Links

Library
Jobs
Staff/student email
Map and travel
Modern Slavery Statement
Donate
Shop
Portal (for current staff/students)
Canvas | Moodle (for current students)

© St George's, University of London  |  Editor Log in

  • Sitemap
  • Cookies
  • Privacy
  • Accessibility
  • Terms & Conditions
  • Print
  • Forgot your password?
  • Forgot your username?